Explorer
Bharat Biotech seeks emergency use approval for Covaxin
After Pfizer and Serum Institute of India (SII), Bharat Biotech has applied for the emergency use approval for its Coronavirus vaccine, Covaxin. The Hyderabad based company has written to written to central drug regulator seeking emergency use authorization.
The vaccine has been developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR)
The vaccine has been developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR)
India
BREAKING NEWS: 'Lungi' Remark Sparks Rajya Sabha Uproar as John Brittas Alleges Insult to South Indians
BIG BREAKING: Rahul Gandhi Demands Amit Shah’s Resignation Over Student Protest Action
BREAKING: Amit Shah Challenges Opposition to Debate, Says Government Ready to Answer Every Question
BIG CLASH: Amit Shah Calls for Parliament Debate as Rahul Gandhi Demands Answers and Accountability
Breaking: Tata Sons Chair N Chandrasekaran Resigns; Term Continues Until February 2027, Shares Fall!
View More
Trending News



















